Pune, India

Purna Chandra Ray

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Maharashtra, IN (2015)
  • Pune, IN (2014 - 2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Purna Chandra Ray: Innovator in Pharmaceutical Chemistry

Introduction

Purna Chandra Ray is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work focuses on developing processes for the preparation of important pharmaceutical compounds.

Latest Patents

One of his latest patents is titled "Process for the preparation of pure and stable crystalline Raltegravir potassium form 3." This invention provides improved, commercially viable, and consistently reproducible processes for the preparation of pure and stable crystalline Raltegravir potassium Form 3 and its pharmaceutical composition. Another significant patent is "Process for preparation of tetrabenazine and deutetrabenazine." This invention outlines a process for preparing dihydroxy benzoquinoline compound by reacting dihydroxy isoquinoline compound or a salt thereof with a specific ammonium iodide and further converting it to tetrabenazine and deutetrabenazine.

Career Highlights

Purna Chandra Ray is currently associated with Lupin, Inc., a prominent player in the pharmaceutical industry. His innovative approaches and dedication to research have positioned him as a valuable asset in his field.

Collaborations

He has collaborated with notable coworkers such as Girij Pal Singh and Surinder Kumar Arora, contributing to various projects and advancements in pharmaceutical research.

Conclusion

Purna Chandra Ray's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to impact the development of essential pharmaceutical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…